Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Major Depressive Disorder (MDD) is a severe and common psychiatric disorder. Although MDD
primarily involves mood disturbances, patients also usually present alterations in cognitive
function (attention, memory, executive functioning and psychomotor speed). Even though
antidepressants are suggested in the literature to potentially improve cognitive dysfunction
in patients with MDD to some degree, there is a lack of adequate and well-controlled studies
to investigate this effect. This study will evaluate the efficacy, safety and tolerability of
a new antidepressant Vortioxetine versus placebo on cognitive dysfunction in adult patients
with MDD.